Key Takeaways
- Revenue up 21% YoY, but standalone margins cratered: Consolidated revenue grew ~21% YoY on chemical and pharma traction, but standalone EBITDA margin halved from ~25% to 16.5% as the business cycled from abnormally cheap steel into high-cost inventory.
- International margins turned the corner: International EBITDA margin improved to 13% from 10%, driven by pricing actions, a 4-day work week in Germany cutting energy use, M&A turnarounds, and a growing higher-margin services mix.
- The backlog is deep, and the furnace is bigger: Order backlog of INR 2,119 crores gives 6–9 months of visibility, and India's largest 80,000-liter furnace is now online with its first super-large vessel order already in fabrication.
- 100% profit consolidation from Q3: The balance 46% stake in Pfaudler International was acquired, eliminating the non-controlling interest; all international profits now accrue to the parent from October 1.
- What to watch next quarter: Whether standalone margins normalize in H2 as the high-cost steel inventory works through, whether the large-project pipeline converts into orders, and whether the Edlon sale process reaches a conclusion.
Standalone Margin Compression
- The steel inventory trap: Standalone EBITDA margin fell from ~25% in H1 FY22 to 16.5% in Q2 FY23 because H1 FY22 was still consuming old, lower-cost steel plates, while H1 FY23 consumed higher-cost inventory. Management expects this to normalize in H2 as the expensive plates cycle through.
- The comp was abnormal anyway: Last year's ~25% EBITDA benefited from strong commodity tailwinds; the current margin reflects the opposite effect of high commodity prices, and management frames the prior period as the outlier rather than the current one.
- Other expenses added pressure: Standalone other expenses rose ~INR 20 crores YoY, driven by a mix shift toward heavy engineering and higher freight outward from larger export shipments in H1 and Q2.
- Working capital stretched: A slight increase in working capital came primarily from heavy engineering taking a larger share of the business, plus some debtors needing recovery in the standalone India business. Unbilled revenues scaled up with ~INR 90 crores of POC addition in H1; management expects ~INR 30–40 crores improvement in H2.
Aseem Joshi: "First of all, the basis for comparison this year is a little unfortunate last year, this time, we were really benefiting from the strong tailwinds, and we were achieving close to 25% EBITDA. That was quite abnormal."
International Business Turnaround
- Margin step-change: International EBITDA margin improved to 13% from 10%, and management expects it to sustain at around 12–13%. The improvement came from multiple levers: pricing actions that built in material and energy cost increases, a shift to a 4-day work week in Germany that reduced gas and energy consumption, addition of new businesses through M&A showing turnaround and growth, and a growing higher-margin services component as factories reopen post-pandemic.
- Energy costs peaked: Energy costs increased from late calendar 2021 and became acute from February–April 2022, but have stabilized or even reduced in recent weeks. Management believes the business is past the highest level, and any further improvement will have a good impact on the rest of the year.
- Services and non-glass-line growth: The services component was smaller during the pandemic; now factories are reopening and the services part is growing, which is more profitable. The non-glass-line product portfolio, though small in market share, is seeing good growth using the Pfaudler network globally, with products sold into plant-based meat, bioplastics, metals and minerals, and the power sector.
- Consolidation complete: The balance 46% stake in Pfaudler International was acquired, eliminating the non-controlling interest as of September 30. 100% of profits will accrue from Q3 onwards, and no non-controlling interest will appear from Q3.
Alexander Pömpner: "We were already behind 2% on some margin improvement, and this now drops through. So, it currently overcompensates the energy cost increases."
Order Book & Capacity Expansion
- Deep backlog, selective intake: The current order backlog of INR 2,119 crores gives visibility for the next 6 to 9 months. Management has been selective on glass-lined orders in India, saying no to customers when the price did not meet requirements, and believes having any more backlog would mean longer delivery times, which would not be the right place to be.
- India's largest furnace online: An 80,000-liter furnace was commissioned at Karamsad, bringing India glass-line capacity to 2,900–3,000 EUs per year. The first order for 3 x 80,000-liter storage tanks has been received and fabrication started, with another 5 x 80,000 liters expected.
- Vatva facility full and firing: The Vatva site is now full, ramp-up has met expectations over the ~18 months since takeover, and record production was achieved in some cases, including record size of equipment shipped.
- Large projects moving: Large projects in India are starting to move forward; one big order already received, several more on the horizon where the company feels competitively placed. Smaller run-rate business remains sluggish. Order finalization timelines are slightly longer than earlier; customers may take a few months more.
- Europe demand holding: Management is not seeing any slowdown on the ground in Europe; opportunity levels, interest levels, and inquiries remain at pretty much the same level. Customers are willing to wait for delivery, and the existing order book provides comfort for the next 6–9 months across different regions, shifting focus to execution.
Tarak Patel: "People don't even need it immediately, and they're willing to wait. But the order book that we have, gives us a lot of the comfort, right. So that the next 6 months, 9 months in different regions, we already have orders on hand, and our focus really shift to the execution."
Portfolio & M&A
- Hydro Air Research Italia acquired: The acquisition was completed; the company deals in membrane separation systems and opens new industries. Management expects to double that business (~$8 million) in the short term, with interesting work underway in bioplastics and bio-based industries.
- Mixion scaling fast: Mixion has seen significant growth with a complementary product used in the same industries; it is profitable and has made major breakthroughs into fermentation, metals and minerals, and paints. It is likely the biggest mixing player in India, with revenue expected to be twice as much as last year's INR 60-odd crores. International expansion would probably need local manufacturing, and an M&A opportunity would be very interesting.
- Interseal launched in India: The sealing technology business, which has performed exceedingly well, was launched in India and has already won orders for ~20 seals.
- Systems business emerging: An acid recovery project from a power company converting sulfur emissions to sulphuric acid brings in glass-lined equipment as well; the systems business has potential to scale as India is just starting on this front.
- Edlon sale still in play: While the sale process is ongoing, Edlon has done quite well with a large order backlog and significantly improved profitability. Management is still reviewing and will update when there is news.
- Portfolio always under review: M&A is a very important part of the growth strategy; certain businesses do not fit well, new ones fit better, and management is always looking at opportunities to increase and improve the portfolio.
Tarak Patel: "I think that's going to be the cornerstone of our growth strategy as well as in M&A is in a very important part of our growth strategy. And we always have interest in increasing and improving our portfolio."
India Demand & Services Push
- Chemicals lead, pharma lags: The main demand drivers in India have been the chemical industry, both agro and specialty chemicals. Pharma has been much slower, though some traction is seen in PLI schemes, especially penicillin manufacturing where three large fermentation orders were received.
- Services organization built: A service leader was appointed in the India business this quarter, mirroring the international business structure. Actions are underway on customer approach, installed base analysis, service offerings, and pricing, with improvement expected from the new focus.
- Hyderabad facility upgraded: A new furnace was commissioned at Hyderabad, and some factory sheds are being renovated. There is no relocation plan currently, though when Pharma City becomes available, management would like to look at it as an alternative production facility.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Standalone margin normalization | Margins to improve as high-cost steel inventory cycles through | H2 FY23 (Q3 and Q4) |
| International margin sustainability | Sustain at around 12–13% | Ongoing |
| Unbilled revenue improvement | ~INR 30–40 crores improvement expected | H2 FY23 |
| Effective tax rate | Sustained at ~27% | Ongoing |
| Hydro Air revenue | Double the business (~$8 million) | Short term |
| Mixion India revenue | Twice as much as last year's INR 60-odd crores | Current year |
| Non-controlling interest | No NCI from Q3; 100% profit accrual from October 1 | Q3 FY23 onwards |
| Energy cost impact | Past the highest level; further improvement benefits rest of year | Rest of FY23 |
Key Metrics
| Metric | Q2 FY23 |
|---|---|
| Consolidated revenue growth | Close to 21% YoY |
| Consolidated EBITDA margin | 15.2%, improved from prior periods |
| Consolidated EBITDA | ~₹119 cr (per an analyst's math) |
| Standalone EBITDA | ₹42 cr (per an analyst's math) |
| Standalone EBITDA margin | 16.5%, down from 25% in H1 FY22 |
| International business EBITDA margin | 13%, improved from 10% in recent past |
| International business H1 EBITDA margin | ~11% |
| Order intake growth | 6% YoY |
| Order backlog | ₹2,119 cr, providing 6–9 months visibility |
| Net debt | ₹467 cr, gross debt ₹767 cr minus ₹300 cr cash |
| Net debt to equity | 0.7 |
| Net debt to EBITDA | 1.1 |
| Sustained effective tax rate | ~27% |
| India glass-lined capacity | 2,900–3,000 EUs per year with new furnace |
| Karamsad and Hyderabad utilization | 80–90% before new furnace commissioning |
| Patel family stake | 24.2%, up from ~22% via pref allotment |
| DBAG stake | 31%, with 3-year lock-in |
| Mixion India revenue | ~₹60 cr last year, expected to double this year |
| Hydro Air business size | ~$8 mn |
| Interseal business size | ~$10–11 mn, up from ~$3 mn |
| Interseal large order won | ~$2 mn |
| Acid recovery order from power company | ₹20 cr+ |
| Unbilled revenue (POC) addition in H1 | ~₹90 cr (per an analyst's math) |
| Standalone other expenses increase | ~₹20 cr YoY |